| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institutes of Internal Medicine, 2 Anatomical Pathology, and 3 Medical Biochemistry, University of Stellenbosch Medical School, Tyberberg Hospital, Cape Town, South Africa
CORRESPONDENCE: A.H. Diacon, Dept of Internal Medicine, University of Stellenbosch Medical School, PO Box 19063, 7505, Tygerberg, Cape Town, South Africa. Fax: 27 219317442. E-mail: ahd@sun.ac.za
Keywords: closed needle biopsy, pleural effusion, thoracoscopy, tuberculosis
Received: February 14, 2003
Accepted April 25, 2003
This study was supported by the Tuberculosis Fund, University of Stellenbosch, Cape Town, South Africa. A.H. Diacon was partly supported by the local Respiratory Research Unit Fund and a postdoctoral research fellowship from the University of Stellenbosch.
Thoracoscopy is the most accurate yet most expensive tool for establishing the diagnosis of tuberculous (TB) pleurisy. However, most high TB-incidence regions have limited financial resources, lack the infrastructure needed for routine thoracoscopy and require an alternative, costeffective diagnostic approach for pleural effusions.
Altogether, 51 patients with undiagnosed exudative pleural effusions were recruited for a prospective, direct comparison between bronchial wash, pleural fluid microbiology and biochemistry (adenosine deaminase (ADA) and cell count), closed needle biopsy, and medical thoracoscopy.
The final diagnosis was TB in 42 patients (82%), malignancy in five (10%) and idiopathic in four patients (8%). Sensitivity of histology, culture and combined histology/culture was 66, 48 and 79%, respectively for closed needle biopsy and 100, 76 and 100%, respectively for thoracoscopy. Both were 100% specific. Pleural fluid ADA of
A combination of pleural fluid adenosine deaminase, differential cell count and closed needle biopsy has a high diagnostic accuracy in undiagnosed exudative pleural effusions in areas with high incidences of tuberculosis and might substitute medical thoracoscopy at considerably lower expense in resourcepoor countries.
50 U·L–1 was 95% sensitive and 89% specific. Combined ADA, lymphocyte/neutrophil ratio 0.75 plus closed needle biopsy reached 93% sensitivity and 100% specificity.
This article has been cited by other articles:
|
|
 |
|
  S. Elia, R. Massoud, G. Guggino, B. Cristino, C. Cortese, A. R. De Massimi, and R. Zenobi Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 723 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gopi, S. M. Madhavan, S. K. Sharma, and S. A. Sahn Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006 Chest, March 1, 2007; 131(3): 880 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N M Rahman, R J O Davies, and F V Gleeson Investigating suspected malignant pleural effusion BMJ, January 27, 2007; 334(7586): 206 - 207. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rodriguez-Panadero, J. P. Janssen, and P. Astoul Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur. Respir. J., August 1, 2006; 28(2): 409 - 422. [Full Text] [PDF]
|
|
|
|
|
|
J. Ferrer, J. Roldan, J. Teixidor, E. Pallisa, I. Gich, and F. Morell Predictors of Pleural Malignancy in Patients With Pleural Effusion Undergoing Thoracoscopy Chest, March 1, 2005; 127(3): 1017 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Light Tumor Markers in Undiagnosed Pleural Effusions Chest, December 1, 2004; 126(6): 1721 - 1722. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
